Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
A research collaboration with Amgen uses Ro's real-world platform data to study barriers to care, insurance coverage decisions, prior authorization requirements, and patient treatment experience in obesityprecisely the kind of access intelligence pharma partners need when studying coverage gaps ahead of new drug launches
Only the specific numbers will change
The mean duration of exposure to semaglutide or placebo was 34.2 13.7 months
Follow the recommended dosage and duration provided by your healthcare professional
US$ 24.72
US$ 22.91
US$ 20.98
US$ 23.66
